APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemotherapy Induced Anemia Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chemotherapy Induced Anemia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchChemotherapy Induced Anemia Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemotherapy Induced Anemia Drug Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Chemotherapy Induced Anemia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemotherapy Induced Anemia Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemotherapy Induced Anemia Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Chemotherapy Induced Anemia Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chemotherapy Induced Anemia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chemotherapy Induced Anemia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chemotherapy Induced Anemia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chemotherapy Induced Anemia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chemotherapy Induced Anemia Drug include Chong Kun Dang Pharmaceutical Corp., Sandoz International GmbH, Pfizer Inc., Tolero Pharmaceuticals, Inc., Therapure Biopharma Inc., SBI Pharmaceuticals Co., Ltd., Pieris Pharmaceuticals Inc, PhytoHealth Corporation and PharmaEssentia Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chemotherapy Induced Anemia Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chemotherapy Induced Anemia Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chemotherapy Induced Anemia Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chemotherapy Induced Anemia Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Chemotherapy Induced Anemia Drug Segment by Company

Chong Kun Dang Pharmaceutical Corp.

Sandoz International GmbH

Pfizer Inc.

Tolero Pharmaceuticals, Inc.

Therapure Biopharma Inc.

SBI Pharmaceuticals Co., Ltd.

Pieris Pharmaceuticals Inc

PhytoHealth Corporation

PharmaEssentia Corporation

Panacea Biotec Limited

Galenica Ltd.

Dr. Reddy's Laboratories Limited

BIOCAD

3SBio Inc.

Chemotherapy Induced Anemia Drug Segment by Type

Pegylated Erythropoietin

Ferric Carboxymaltose

Epoetin Zeta Biosimilar

Others

Chemotherapy Induced Anemia Drug Segment by Application

Clinic

Hospital

Homecare

Chemotherapy Induced Anemia Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotherapy Induced Anemia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemotherapy Induced Anemia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotherapy Induced Anemia Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chemotherapy Induced Anemia Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chemotherapy Induced Anemia Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chemotherapy Induced Anemia Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chemotherapy Induced Anemia Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chemotherapy Induced Anemia Drug Industry Trends Table 2. Chemotherapy Induced Anemia Drug Industry Drivers Table 3. Chemotherapy Induced Anemia Drug Industry Opportunities and Challenges Table 4. Chemotherapy Induced Anemia Drug Industry Restraints Table 5. Global Chemotherapy Induced Anemia Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chemotherapy Induced Anemia Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Chemotherapy Induced Anemia Drug Sales Market Share by Manufacturers Table 9. Global Chemotherapy Induced Anemia Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Chemotherapy Induced Anemia Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chemotherapy Induced Anemia Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chemotherapy Induced Anemia Drug Manufacturers, Product Type & Application Table 13. Global Chemotherapy Induced Anemia Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chemotherapy Induced Anemia Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pegylated Erythropoietin Table 17. Major Manufacturers of Ferric Carboxymaltose Table 18. Major Manufacturers of Epoetin Zeta Biosimilar Table 19. Major Manufacturers of Others Table 20. Global Chemotherapy Induced Anemia Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (k units) Table 22. Global Chemotherapy Induced Anemia Drug Sales by Type (2027-2032) & (k units) Table 23. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2021-2026) Table 24. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2027-2032) Table 25. Global Chemotherapy Induced Anemia Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Chemotherapy Induced Anemia Drug Revenue by Type (2021-2026) & (k units) Table 27. Global Chemotherapy Induced Anemia Drug Revenue by Type (2027-2032) & (k units) Table 28. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2021-2026) Table 29. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Homecare Table 33. Global Chemotherapy Induced Anemia Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (k units) Table 35. Global Chemotherapy Induced Anemia Drug Sales by Application (2027-2032) & (k units) Table 36. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2021-2026) Table 37. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2027-2032) Table 38. Global Chemotherapy Induced Anemia Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Chemotherapy Induced Anemia Drug Revenue by Application (2021-2026) & (k units) Table 40. Global Chemotherapy Induced Anemia Drug Revenue by Application (2027-2032) & (k units) Table 41. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2021-2026) Table 42. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2027-2032) Table 43. Global Chemotherapy Induced Anemia Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Chemotherapy Induced Anemia Drug Sales by Region (2021-2026) & (k units) Table 45. Global Chemotherapy Induced Anemia Drug Sales Market Share by Region (2021-2026) Table 46. Global Chemotherapy Induced Anemia Drug Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Chemotherapy Induced Anemia Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 50. North America Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 51. Europe Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 53. Europe Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 60. Global Chemotherapy Induced Anemia Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Chemotherapy Induced Anemia Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Chemotherapy Induced Anemia Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2021-2026) Table 64. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2027-2032) Table 65. Chong Kun Dang Pharmaceutical Corp. Company Information Table 66. Chong Kun Dang Pharmaceutical Corp. Business Overview Table 67. Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Product Portfolio Table 69. Chong Kun Dang Pharmaceutical Corp. Recent Development Table 70. Sandoz International GmbH Company Information Table 71. Sandoz International GmbH Business Overview Table 72. Sandoz International GmbH Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sandoz International GmbH Chemotherapy Induced Anemia Drug Product Portfolio Table 74. Sandoz International GmbH Recent Development Table 75. Pfizer Inc. Company Information Table 76. Pfizer Inc. Business Overview Table 77. Pfizer Inc. Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 79. Pfizer Inc. Recent Development Table 80. Tolero Pharmaceuticals, Inc. Company Information Table 81. Tolero Pharmaceuticals, Inc. Business Overview Table 82. Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 84. Tolero Pharmaceuticals, Inc. Recent Development Table 85. Therapure Biopharma Inc. Company Information Table 86. Therapure Biopharma Inc. Business Overview Table 87. Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 89. Therapure Biopharma Inc. Recent Development Table 90. SBI Pharmaceuticals Co., Ltd. Company Information Table 91. SBI Pharmaceuticals Co., Ltd. Business Overview Table 92. SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Product Portfolio Table 94. SBI Pharmaceuticals Co., Ltd. Recent Development Table 95. Pieris Pharmaceuticals Inc Company Information Table 96. Pieris Pharmaceuticals Inc Business Overview Table 97. Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Product Portfolio Table 99. Pieris Pharmaceuticals Inc Recent Development Table 100. PhytoHealth Corporation Company Information Table 101. PhytoHealth Corporation Business Overview Table 102. PhytoHealth Corporation Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. PhytoHealth Corporation Chemotherapy Induced Anemia Drug Product Portfolio Table 104. PhytoHealth Corporation Recent Development Table 105. PharmaEssentia Corporation Company Information Table 106. PharmaEssentia Corporation Business Overview Table 107. PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Product Portfolio Table 109. PharmaEssentia Corporation Recent Development Table 110. Panacea Biotec Limited Company Information Table 111. Panacea Biotec Limited Business Overview Table 112. Panacea Biotec Limited Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Panacea Biotec Limited Chemotherapy Induced Anemia Drug Product Portfolio Table 114. Panacea Biotec Limited Recent Development Table 115. Galenica Ltd. Company Information Table 116. Galenica Ltd. Business Overview Table 117. Galenica Ltd. Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Galenica Ltd. Chemotherapy Induced Anemia Drug Product Portfolio Table 119. Galenica Ltd. Recent Development Table 120. Dr. Reddy's Laboratories Limited Company Information Table 121. Dr. Reddy's Laboratories Limited Business Overview Table 122. Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Product Portfolio Table 124. Dr. Reddy's Laboratories Limited Recent Development Table 125. BIOCAD Company Information Table 126. BIOCAD Business Overview Table 127. BIOCAD Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. BIOCAD Chemotherapy Induced Anemia Drug Product Portfolio Table 129. BIOCAD Recent Development Table 130. 3SBio Inc. Company Information Table 131. 3SBio Inc. Business Overview Table 132. 3SBio Inc. Chemotherapy Induced Anemia Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. 3SBio Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 134. 3SBio Inc. Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Chemotherapy Induced Anemia Drug Distributors List Table 138. Chemotherapy Induced Anemia Drug Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Chemotherapy Induced Anemia Drug Product Image Figure 2. Global Chemotherapy Induced Anemia Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemotherapy Induced Anemia Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Chemotherapy Induced Anemia Drug Sales (2021-2032) & (k units) Figure 5. Global Chemotherapy Induced Anemia Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chemotherapy Induced Anemia Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pegylated Erythropoietin Image Figure 9. Ferric Carboxymaltose Image Figure 10. Epoetin Zeta Biosimilar Image Figure 11. Others Image Figure 12. Global Chemotherapy Induced Anemia Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Chemotherapy Induced Anemia Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2021-2032) Figure 15. Global Chemotherapy Induced Anemia Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Chemotherapy Induced Anemia Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Homecare Image Figure 21. Global Chemotherapy Induced Anemia Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Chemotherapy Induced Anemia Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2021-2032) Figure 24. Global Chemotherapy Induced Anemia Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Chemotherapy Induced Anemia Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 41. China Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Chemotherapy Induced Anemia Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Chemotherapy Induced Anemia Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Chemotherapy Induced Anemia Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Chemotherapy Induced Anemia Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Chemotherapy Induced Anemia Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Chemotherapy Induced Anemia Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Chemotherapy Induced Anemia Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Chemotherapy Induced Anemia Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Pegylated Erythropoietin
  • Ferric Carboxymaltose
  • Epoetin Zeta Biosimilar
  • Others
Applications
  • Clinic
  • Hospital
  • Homecare
Companies covered
  • Chong Kun Dang Pharmaceutical Corp.
  • Sandoz International GmbH
  • Pfizer Inc.
  • Tolero Pharmaceuticals, Inc.
  • Therapure Biopharma Inc.
  • SBI Pharmaceuticals Co., Ltd.
  • Pieris Pharmaceuticals Inc
  • PhytoHealth Corporation
  • PharmaEssentia Corporation
  • Panacea Biotec Limited
  • Galenica Ltd.
  • Dr. Reddy's Laboratories Limited
  • BIOCAD
  • 3SBio Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chemotherapy Induced Anemia Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chemotherapy Induced Anemia Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chemotherapy Induced Anemia Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chemotherapy Induced Anemia Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chemotherapy Induced Anemia Drug Market Dynamics
  1. 2.1 Chemotherapy Induced Anemia Drug Industry Trends
  2. 2.2 Chemotherapy Induced Anemia Drug Industry Drivers
  3. 2.3 Chemotherapy Induced Anemia Drug Industry Opportunities and Challenges
  4. 2.4 Chemotherapy Induced Anemia Drug Industry Restraints
3 Chemotherapy Induced Anemia Drug Market by Manufacturers
  1. 3.1 Global Chemotherapy Induced Anemia Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chemotherapy Induced Anemia Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chemotherapy Induced Anemia Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chemotherapy Induced Anemia Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chemotherapy Induced Anemia Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chemotherapy Induced Anemia Drug Manufacturers, Product Type & Application
  7. 3.7 Global Chemotherapy Induced Anemia Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chemotherapy Induced Anemia Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chemotherapy Induced Anemia Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chemotherapy Induced Anemia Drug Tier 1, Tier 2, and Tier 3
4 Chemotherapy Induced Anemia Drug Market by Type
  1. 4.1 Chemotherapy Induced Anemia Drug Type Introduction
  2. 4.1.1 Pegylated Erythropoietin
  3. 4.1.2 Ferric Carboxymaltose
  4. 4.1.3 Epoetin Zeta Biosimilar
  5. 4.1.4 Others
  6. 4.2 Global Chemotherapy Induced Anemia Drug Sales by Type
  7. 4.2.1 Global Chemotherapy Induced Anemia Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Chemotherapy Induced Anemia Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Chemotherapy Induced Anemia Drug Revenue by Type
  11. 4.3.1 Global Chemotherapy Induced Anemia Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Chemotherapy Induced Anemia Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2021-2032)
5 Chemotherapy Induced Anemia Drug Market by Application
  1. 5.1 Chemotherapy Induced Anemia Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Homecare
  5. 5.2 Global Chemotherapy Induced Anemia Drug Sales by Application
  6. 5.2.1 Global Chemotherapy Induced Anemia Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chemotherapy Induced Anemia Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Chemotherapy Induced Anemia Drug Revenue by Application
  10. 5.3.1 Global Chemotherapy Induced Anemia Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Chemotherapy Induced Anemia Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2021-2032)
6 Global Chemotherapy Induced Anemia Drug Sales by Region
  1. 6.1 Global Chemotherapy Induced Anemia Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chemotherapy Induced Anemia Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Chemotherapy Induced Anemia Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Chemotherapy Induced Anemia Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chemotherapy Induced Anemia Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chemotherapy Induced Anemia Drug Revenue by Region
  1. 7.1 Global Chemotherapy Induced Anemia Drug Revenue by Region
  2. 7.1.1 Global Chemotherapy Induced Anemia Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chemotherapy Induced Anemia Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Chemotherapy Induced Anemia Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chemotherapy Induced Anemia Drug Revenue (2021-2032)
  8. 7.2.2 North America Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chemotherapy Induced Anemia Drug Revenue (2021-2032)
  11. 7.3.2 Europe Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chemotherapy Induced Anemia Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chemotherapy Induced Anemia Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chemotherapy Induced Anemia Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chong Kun Dang Pharmaceutical Corp.
  2. 8.1.1 Chong Kun Dang Pharmaceutical Corp. Company Information
  3. 8.1.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
  4. 8.1.3 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Product Portfolio
  6. 8.1.5 Chong Kun Dang Pharmaceutical Corp. Recent Developments
  7. 8.2 Sandoz International GmbH
  8. 8.2.1 Sandoz International GmbH Company Information
  9. 8.2.2 Sandoz International GmbH Business Overview
  10. 8.2.3 Sandoz International GmbH Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz International GmbH Chemotherapy Induced Anemia Drug Product Portfolio
  12. 8.2.5 Sandoz International GmbH Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 Tolero Pharmaceuticals, Inc.
  20. 8.4.1 Tolero Pharmaceuticals, Inc. Company Information
  21. 8.4.2 Tolero Pharmaceuticals, Inc. Business Overview
  22. 8.4.3 Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  24. 8.4.5 Tolero Pharmaceuticals, Inc. Recent Developments
  25. 8.5 Therapure Biopharma Inc.
  26. 8.5.1 Therapure Biopharma Inc. Company Information
  27. 8.5.2 Therapure Biopharma Inc. Business Overview
  28. 8.5.3 Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  30. 8.5.5 Therapure Biopharma Inc. Recent Developments
  31. 8.6 SBI Pharmaceuticals Co., Ltd.
  32. 8.6.1 SBI Pharmaceuticals Co., Ltd. Company Information
  33. 8.6.2 SBI Pharmaceuticals Co., Ltd. Business Overview
  34. 8.6.3 SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Product Portfolio
  36. 8.6.5 SBI Pharmaceuticals Co., Ltd. Recent Developments
  37. 8.7 Pieris Pharmaceuticals Inc
  38. 8.7.1 Pieris Pharmaceuticals Inc Company Information
  39. 8.7.2 Pieris Pharmaceuticals Inc Business Overview
  40. 8.7.3 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Product Portfolio
  42. 8.7.5 Pieris Pharmaceuticals Inc Recent Developments
  43. 8.8 PhytoHealth Corporation
  44. 8.8.1 PhytoHealth Corporation Company Information
  45. 8.8.2 PhytoHealth Corporation Business Overview
  46. 8.8.3 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Product Portfolio
  48. 8.8.5 PhytoHealth Corporation Recent Developments
  49. 8.9 PharmaEssentia Corporation
  50. 8.9.1 PharmaEssentia Corporation Company Information
  51. 8.9.2 PharmaEssentia Corporation Business Overview
  52. 8.9.3 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Product Portfolio
  54. 8.9.5 PharmaEssentia Corporation Recent Developments
  55. 8.10 Panacea Biotec Limited
  56. 8.10.1 Panacea Biotec Limited Company Information
  57. 8.10.2 Panacea Biotec Limited Business Overview
  58. 8.10.3 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Product Portfolio
  60. 8.10.5 Panacea Biotec Limited Recent Developments
  61. 8.11 Galenica Ltd.
  62. 8.11.1 Galenica Ltd. Company Information
  63. 8.11.2 Galenica Ltd. Business Overview
  64. 8.11.3 Galenica Ltd. Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Galenica Ltd. Chemotherapy Induced Anemia Drug Product Portfolio
  66. 8.11.5 Galenica Ltd. Recent Developments
  67. 8.12 Dr. Reddy's Laboratories Limited
  68. 8.12.1 Dr. Reddy's Laboratories Limited Company Information
  69. 8.12.2 Dr. Reddy's Laboratories Limited Business Overview
  70. 8.12.3 Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Product Portfolio
  72. 8.12.5 Dr. Reddy's Laboratories Limited Recent Developments
  73. 8.13 BIOCAD
  74. 8.13.1 BIOCAD Company Information
  75. 8.13.2 BIOCAD Business Overview
  76. 8.13.3 BIOCAD Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BIOCAD Chemotherapy Induced Anemia Drug Product Portfolio
  78. 8.13.5 BIOCAD Recent Developments
  79. 8.14 3SBio Inc.
  80. 8.14.1 3SBio Inc. Company Information
  81. 8.14.2 3SBio Inc. Business Overview
  82. 8.14.3 3SBio Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 3SBio Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  84. 8.14.5 3SBio Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chemotherapy Induced Anemia Drug Value Chain Analysis
  2. 9.1.1 Chemotherapy Induced Anemia Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chemotherapy Induced Anemia Drug Production Mode & Process
  6. 9.2 Chemotherapy Induced Anemia Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chemotherapy Induced Anemia Drug Distributors
  9. 9.2.3 Chemotherapy Induced Anemia Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst